Graphite Bio is a biotechnology business based in the US. Graphite Bio shares (GRPH) are listed on the NASDAQ and all prices are listed in US Dollars. Graphite Bio employs 6 staff and has a market cap (total outstanding shares value) of 0.00.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – GRPH.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Graphite Bio stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Graphite Bio stock price (NASDAQ: GRPH)
Use our graph to track the performance of GRPH stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Graphite Bio financials
Gross profit TTM
$0
Return on assets TTM
-17.99%
Return on equity TTM
-51.95%
Profit margin
0%
Book value
$22.15
Market Capitalization
$185.2 million
TTM: trailing 12 months
Graphite Bio share dividends
We're not expecting Graphite Bio to pay a dividend over the next 12 months.
You may also wish to consider:
Have Graphite Bio's shares ever split?
Graphite Bio's shares were
split on a 1:7 basis on 21 March 2024
. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Graphite Bio shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Graphite Bio shares which in turn could have impacted Graphite Bio's share price.
Graphite Bio share price volatility
Over the last 12 months, Graphite Bio's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Graphite Bio's is 0.196. This would suggest that Graphite Bio's shares are less volatile than average (for this exchange).
To put Graphite Bio's beta into context you can compare it against those of similar companies.
As of March 21, 2024, Graphite Bio, Inc. was acquired by LENZ Therapeutics, Inc. , in a reverse merger transaction. Graphite Bio, Inc. , a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme.
Frequently asked questions
null What percentage of Graphite Bio is owned by insiders or institutions? Currently 9.179% of Graphite Bio shares are held by insiders and 84.43% by institutions.How many people work for Graphite Bio? Latest data suggests 6 work at Graphite Bio.When does the fiscal year end for Graphite Bio? Graphite Bio's fiscal year ends in December.Where is Graphite Bio based? Graphite Bio's address is: 611 Gateway Boulevard, South San Francisco, CA, United States, 94080What is Graphite Bio's ISIN number? Graphite Bio's international securities identification number is: US38870X1046What is Graphite Bio's CUSIP number? Graphite Bio's Committee on Uniform Securities Identification Procedures number is: 38870X104
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
